 |
|
|
|
 |
| AUGUST 20 ,
2009 | ISSUE NUMBER 112 VOL 6 |
R&D
Lilly Osteoporosis Drug Canned in Phase III Trials
Lilly was banking that arzoxifene might fill some of its pipeline gaps, but alas, the osteoporosis treatment failed to meet secondary endpoint and has been shelved.
Government
Tauzin to Boener: Don’t “Bully” Me
Apparently unswayed by the Republican Whip¹s poison-pen missive, PhRMA head Billy Tauzin reaffirms his decision to play nice with Obama.
Regulatory
Integrating EU and US Regulation
Pharmaceutical Technology Europe interviews Sylvia M. Findlay, program leader at Frost & Sullivan, which recently released a report entitled “Drug Approval Process in Europe—An Outlook.” Findlay believes that integration of the EU and US drug approval processes is a necessity.
Vaccines
H1N1 Vaccine Quantities to Fall Short of Predictions
The feds might have been a little hopeful when they stated that 120 million doses of a new H1N1 vaccine would be available in advance of the Fall flu season. That number being bandied about now is about 45 million vaccines to start with. So what’s the hold up?
|
Advertisement:
Simultaneously improve laboratory productivity, efficiency and throughput
With [ACQUITY UPLC®] we got some phenomenal results which we could just not do with HPLC…For us, it was a logical solution that we had to look then to putting UPLC® on the front end of our mass spec systems. It would increase our throughput, up our instrument utilization, and make much more efficient use of the equipment that we have.
 See ACQUITY UPLC success stories.
|
 |
|  US Oncology appointed Bruce Broussard to chairman of the board // Health Decisions appointed Craig Hurt as controller //
Pharmaceutical Institute appointed Garry O'Grady to senior vice president and general manager // Vox Medica added Bridgit Lombard to its team as general manager and brand development officer // BioDelivery Sciences promoted Dave Wright to vice president of regulatory affairs // The American College of Chest Physicians named Paul A. Markowski the new executive vice president and CEO for the international medical specialty society // In a ceremony recognizing “Chicago’s 101 Best and Brightest Companies to Work For,” Astellas Pharma US won an Elite award for employee engagement and commitment by the National Association for Business Resources //CommonHealth promoted Renee Napoli to media director; Kristine Dyer to associate media director; Carla Roper to media planner; and Erica Hochstuhl to media coordinator // Cempra Pharmaceuticals appointed John H. Johnson, CEO of ImClone Systems, to its board of directors //
|
Advertisement:
Saint Joseph’s University’s Executive Pharmaceutical Marketing MBA Program proudly presents Innovative and Collaborative ePharma Strategies, a Pharma Summit. This one-day conference, held at the ACE Conference Center in Lafayette Hill, PA, will be focused on innovations and marketing strategies in the e-pharma landscape. Issues to be discussed include social media, physician and patient communities, and regulatory and privacy issues.
 Click here for more information.
|
September
10 An Evolving Standard for Success: Proving Product Value Through Comparative Effectiveness Data
Wednesday, September 10 at 11 AM EDT
September 14 Develop Competitive Advantage Through Business Analytics in the New Pharmaceutical Commercial Model
Wednesday, September 14 at 11 AM EDT
|
September
14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry,
Philadelphia, PA
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
September
30 Prix Galien 2009 Awards Ceremony, New York, NY
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California
October
20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA |
|
|
|
 |
|
 |
|
 |
| Are you seeking to build a defined strategic capability to communicate and engage in this emerging area of cyberspace? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
